MIGUEL ANGEL
SERRA DESFILIS
CATEDRÁTICO/A DE UNIVERSIDAD
Publicaciones (150) Publicaciones de MIGUEL ANGEL SERRA DESFILIS
2024
-
Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR–MASH score
Liver International, Vol. 44, Núm. 1, pp. 202-213
-
Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease
Journal of Hepatology
2023
-
Effect of dietary supplementation of citrus flavonoids on performance, intestinal epithelium morphology, microbiota in excreta and oxidative stress of broiler chickens subjected to heat stress
European Poultry Science, Vol. 87
-
Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy
Gastroenterologia y Hepatologia, Vol. 46, Núm. 8, pp. 594-602
-
Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver
Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 3, pp. 128-132
-
Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction
Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 150-162
2022
-
Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease
Radiology, Vol. 302, Núm. 2, pp. 345-354
-
Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy
Scientific Reports, Vol. 12, Núm. 1
-
Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology
Liver International, Vol. 42, Núm. 8, pp. 1783-1792
2021
-
Digital pathology enables automated and quantitative assessment of inflammatory activity in patients with chronic liver disease
Biomolecules, Vol. 11, Núm. 12
-
Digital pathology: accurate technique for quantitative assessment of histological features in metabolic-associated fatty liver disease
Alimentary Pharmacology and Therapeutics, Vol. 53, Núm. 1, pp. 160-171
-
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium
Journal of Hepatology, Vol. 74, Núm. 1, pp. 200-219
-
High liver stiffness values by transient elastography related to metabolic syndrome and harmful alcohol use in a large Spanish cohort
United European Gastroenterology Journal, Vol. 9, Núm. 8, pp. 892-902
-
Let's End HepC: Modelling Public Health Epidemiological Policies Applied to Hepatitis C in Spain
Frontiers in Public Health, Vol. 9
-
Sars-cov-2 vs. Hepatitis virus infection risk in the hemodialysis population: What should we expect?
International Journal of Environmental Research and Public Health
2020
-
Epidemiology of hepatitis C virus infection in a country with universal access to direct-acting antiviral agents: Data for designing a cost-effective elimination policy in Spain
Journal of Viral Hepatitis, Vol. 27, Núm. 4, pp. 360-370
-
Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study
Alimentary Pharmacology and Therapeutics, Vol. 52, Núm. 3, pp. 500-512
-
Update on epidemiology of hepatitis B in a low-endemic European country: There is still much to do
Journal of Viral Hepatitis, Vol. 27, Núm. 11, pp. 1261-1265
2019
2018
-
Cirrhotic patients with minimal hepatic encephalopathy have increased capacity to eliminate superoxide and peroxynitrite in lymphocytes, associated with cognitive impairment
Free Radical Research, Vol. 52, Núm. 1, pp. 118-133